Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVE: Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate. CONCLUSION: Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.

Original publication

DOI

10.2214/AJR.04.1516

Type

Journal article

Journal

AJR Am J Roentgenol

Publication Date

02/2006

Volume

186

Pages

510 - 515

Keywords

Aged, Aged, 80 and over, Benzamides, Contrast Media, Female, Gastrointestinal Stromal Tumors, Humans, Image Processing, Computer-Assisted, Imatinib Mesylate, Iopamidol, Male, Middle Aged, Piperazines, Protein Kinase Inhibitors, Pyrimidines, Tomography, X-Ray Computed, Treatment Outcome